List of Tables
Table 1. Global Human Microbiome Sequencing Services Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Human Microbiome Sequencing Services Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Human Microbiome Sequencing Services Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Human Microbiome Sequencing Services Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Human Microbiome Sequencing Services Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Human Microbiome Sequencing Services Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Human Microbiome Sequencing Services Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Human Microbiome Sequencing Services by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Microbiome Sequencing Services as of 2024)
Table 11. Global Human Microbiome Sequencing Services Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Human Microbiome Sequencing Services Companies Headquarters
Table 13. Global Human Microbiome Sequencing Services Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Human Microbiome Sequencing Services Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Human Microbiome Sequencing Services Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Human Microbiome Sequencing Services Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Human Microbiome Sequencing Services Revenue by Application (2026-2031) & (US$ Million)
Table 21. Human Microbiome Sequencing Services High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Human Microbiome Sequencing Services Growth Accelerators and Market Barriers
Table 25. North America Human Microbiome Sequencing Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Human Microbiome Sequencing Services Growth Accelerators and Market Barriers
Table 27. Europe Human Microbiome Sequencing Services Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Human Microbiome Sequencing Services Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Human Microbiome Sequencing Services Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Human Microbiome Sequencing Services Investment Opportunities and Key Challenges
Table 31. Central and South America Human Microbiome Sequencing Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Human Microbiome Sequencing Services Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Human Microbiome Sequencing Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Illumina Corporation Information
Table 35. Illumina Description and Major Businesses
Table 36. Illumina Product Features and Attributes
Table 37. Illumina Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Illumina Revenue Proportion by Product in 2024
Table 39. Illumina Revenue Proportion by Application in 2024
Table 40. Illumina Revenue Proportion by Geographic Area in 2024
Table 41. Illumina Human Microbiome Sequencing Services SWOT Analysis
Table 42. Illumina Recent Developments
Table 43. IGATech Corporation Information
Table 44. IGATech Description and Major Businesses
Table 45. IGATech Product Features and Attributes
Table 46. IGATech Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. IGATech Revenue Proportion by Product in 2024
Table 48. IGATech Revenue Proportion by Application in 2024
Table 49. IGATech Revenue Proportion by Geographic Area in 2024
Table 50. IGATech Human Microbiome Sequencing Services SWOT Analysis
Table 51. IGATech Recent Developments
Table 52. Genetic Analysis Corporation Information
Table 53. Genetic Analysis Description and Major Businesses
Table 54. Genetic Analysis Product Features and Attributes
Table 55. Genetic Analysis Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Genetic Analysis Revenue Proportion by Product in 2024
Table 57. Genetic Analysis Revenue Proportion by Application in 2024
Table 58. Genetic Analysis Revenue Proportion by Geographic Area in 2024
Table 59. Genetic Analysis Human Microbiome Sequencing Services SWOT Analysis
Table 60. Genetic Analysis Recent Developments
Table 61. BaseClear Corporation Information
Table 62. BaseClear Description and Major Businesses
Table 63. BaseClear Product Features and Attributes
Table 64. BaseClear Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. BaseClear Revenue Proportion by Product in 2024
Table 66. BaseClear Revenue Proportion by Application in 2024
Table 67. BaseClear Revenue Proportion by Geographic Area in 2024
Table 68. BaseClear Human Microbiome Sequencing Services SWOT Analysis
Table 69. BaseClear Recent Developments
Table 70. Microba Life Sciences Corporation Information
Table 71. Microba Life Sciences Description and Major Businesses
Table 72. Microba Life Sciences Product Features and Attributes
Table 73. Microba Life Sciences Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Microba Life Sciences Revenue Proportion by Product in 2024
Table 75. Microba Life Sciences Revenue Proportion by Application in 2024
Table 76. Microba Life Sciences Revenue Proportion by Geographic Area in 2024
Table 77. Microba Life Sciences Human Microbiome Sequencing Services SWOT Analysis
Table 78. Microba Life Sciences Recent Developments
Table 79. Viome Corporation Information
Table 80. Viome Description and Major Businesses
Table 81. Viome Product Features and Attributes
Table 82. Viome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Viome Recent Developments
Table 84. Goodgut Corporation Information
Table 85. Goodgut Description and Major Businesses
Table 86. Goodgut Product Features and Attributes
Table 87. Goodgut Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Goodgut Recent Developments
Table 89. Origin Sciences Corporation Information
Table 90. Origin Sciences Description and Major Businesses
Table 91. Origin Sciences Product Features and Attributes
Table 92. Origin Sciences Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Origin Sciences Recent Developments
Table 94. Ixcela Corporation Information
Table 95. Ixcela Description and Major Businesses
Table 96. Ixcela Product Features and Attributes
Table 97. Ixcela Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Ixcela Recent Developments
Table 99. ProDigest Corporation Information
Table 100. ProDigest Description and Major Businesses
Table 101. ProDigest Product Features and Attributes
Table 102. ProDigest Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. ProDigest Recent Developments
Table 104. Enterome Corporation Information
Table 105. Enterome Description and Major Businesses
Table 106. Enterome Product Features and Attributes
Table 107. Enterome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. Enterome Recent Developments
Table 109. The BioCollective Corporation Information
Table 110. The BioCollective Description and Major Businesses
Table 111. The BioCollective Product Features and Attributes
Table 112. The BioCollective Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. The BioCollective Recent Developments
Table 114. ZOE Corporation Information
Table 115. ZOE Description and Major Businesses
Table 116. ZOE Product Features and Attributes
Table 117. ZOE Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. ZOE Recent Developments
Table 119. Qiagen Corporation Information
Table 120. Qiagen Description and Major Businesses
Table 121. Qiagen Product Features and Attributes
Table 122. Qiagen Revenue (US$ Million) and Gross Margin (2020-2025)
Table 123. Qiagen Recent Developments
Table 124. Raw Materials Key Suppliers
Table 125. Distributors List
Table 126. Market Trends and Market Evolution
Table 127. Market Drivers and Opportunities
Table 128. Market Challenges, Risks, and Restraints
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Microbiome Sequencing Services Product Picture
Figure 2. Global Human Microbiome Sequencing Services Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. 16S rRNA Sequencing Product Picture
Figure 4. Shot Gun Metagenomics Product Picture
Figure 5. Metatranscriptomics Product Picture
Figure 6. Others Product Picture
Figure 7. Global Human Microbiome Sequencing Services Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Hospitals
Figure 9. Research Institutes
Figure 10. Pharmaceutical Companies
Figure 11. Human Microbiome Sequencing Services Report Years Considered
Figure 12. Global Human Microbiome Sequencing Services Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Human Microbiome Sequencing Services Revenue (2020-2031) & (US$ Million)
Figure 14. Global Human Microbiome Sequencing Services Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Human Microbiome Sequencing Services Revenue Market Share by Region (2020-2031)
Figure 16. Global Human Microbiome Sequencing Services Revenue Market Share Ranking (2024)
Figure 17. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 18. 16S rRNA Sequencing Revenue Market Share by Player in 2024
Figure 19. Shot Gun Metagenomics Revenue Market Share by Player in 2024
Figure 20. Metatranscriptomics Revenue Market Share by Player in 2024
Figure 21. Others Revenue Market Share by Player in 2024
Figure 22. Global Human Microbiome Sequencing Services Revenue Market Share by Type (2020-2031)
Figure 23. Global Human Microbiome Sequencing Services Revenue Market Share by Application (2020-2031)
Figure 24. North America Human Microbiome Sequencing Services Revenue YoY (2020-2031) & (US$ Million)
Figure 25. North America Top 5 Players Human Microbiome Sequencing Services Revenue (US$ Million) in 2024
Figure 26. North America Human Microbiome Sequencing Services Revenue (US$ Million) by Type (2020 - 2031)
Figure 27. North America Human Microbiome Sequencing Services Revenue (US$ Million) by Application (2020-2031)
Figure 28. US Human Microbiome Sequencing Services Revenue (2020-2031) & (US$ Million)
Figure 29. Canada Human Microbiome Sequencing Services Revenue (2020-2031) & (US$ Million)
Figure 30. Mexico Human Microbiome Sequencing Services Revenue (2020-2031) & (US$ Million)
Figure 31. Europe Human Microbiome Sequencing Services Revenue YoY (2020-2031) & (US$ Million)
Figure 32. Europe Top 5 Players Human Microbiome Sequencing Services Revenue (US$ Million) in 2024
Figure 33. Europe Human Microbiome Sequencing Services Revenue (US$ Million) by Type (2020-2031)
Figure 34. Europe Human Microbiome Sequencing Services Revenue (US$ Million) by Application (2020-2031)
Figure 35. Germany Human Microbiome Sequencing Services Revenue (2020-2031) & (US$ Million)
Figure 36. France Human Microbiome Sequencing Services Revenue (2020-2031) & (US$ Million)
Figure 37. U.K. Human Microbiome Sequencing Services Revenue (2020-2031) & (US$ Million)
Figure 38. Italy Human Microbiome Sequencing Services Revenue (2020-2031) & (US$ Million)
Figure 39. Russia Human Microbiome Sequencing Services Revenue (2020-2031) & (US$ Million)
Figure 40. Asia-Pacific Human Microbiome Sequencing Services Revenue YoY (2020-2031) & (US$ Million)
Figure 41. Asia-Pacific Top 8 Players Human Microbiome Sequencing Services Revenue (US$ Million) in 2024
Figure 42. Asia-Pacific Human Microbiome Sequencing Services Revenue (US$ Million) by Type (2020-2031)
Figure 43. Asia-Pacific Human Microbiome Sequencing Services Revenue (US$ Million) by Application (2020-2031)
Figure 44. Indonesia Human Microbiome Sequencing Services Revenue (2020-2031) & (US$ Million)
Figure 45. Japan Human Microbiome Sequencing Services Revenue (2020-2031) & (US$ Million)
Figure 46. South Korea Human Microbiome Sequencing Services Revenue (2020-2031) & (US$ Million)
Figure 47. Australia Human Microbiome Sequencing Services Revenue (2020-2031) & (US$ Million)
Figure 48. India Human Microbiome Sequencing Services Revenue (2020-2031) & (US$ Million)
Figure 49. Indonesia Human Microbiome Sequencing Services Revenue (2020-2031) & (US$ Million)
Figure 50. Vietnam Human Microbiome Sequencing Services Revenue (2020-2031) & (US$ Million)
Figure 51. Malaysia Human Microbiome Sequencing Services Revenue (2020-2031) & (US$ Million)
Figure 52. Philippines Human Microbiome Sequencing Services Revenue (2020-2031) & (US$ Million)
Figure 53. Singapore Human Microbiome Sequencing Services Revenue (2020-2031) & (US$ Million)
Figure 54. Central and South America Human Microbiome Sequencing Services Revenue YoY (2020-2031) & (US$ Million)
Figure 55. Central and South America Top 5 Players Human Microbiome Sequencing Services Revenue (US$ Million) in 2024
Figure 56. Central and South America Human Microbiome Sequencing Services Revenue (US$ Million) by Type (2020-2031)
Figure 57. Central and South America Human Microbiome Sequencing Services Revenue (US$ Million) by Application (2020-2031)
Figure 58. Brazil Human Microbiome Sequencing Services Revenue (2020-2025) & (US$ Million)
Figure 59. Argentina Human Microbiome Sequencing Services Revenue (2020-2025) & (US$ Million)
Figure 60. Middle East and Africa Human Microbiome Sequencing Services Revenue YoY (2020-2031) & (US$ Million)
Figure 61. Middle East and Africa Top 5 Players Human Microbiome Sequencing Services Revenue (US$ Million) in 2024
Figure 62. South America Human Microbiome Sequencing Services Revenue (US$ Million) by Type (2020-2031)
Figure 63. Middle East and Africa Human Microbiome Sequencing Services Revenue (US$ Million) by Application (2020-2031)
Figure 64. GCC Countries Human Microbiome Sequencing Services Revenue (2020-2025) & (US$ Million)
Figure 65. Israel Human Microbiome Sequencing Services Revenue (2020-2025) & (US$ Million)
Figure 66. Egypt Human Microbiome Sequencing Services Revenue (2020-2025) & (US$ Million)
Figure 67. South Africa Human Microbiome Sequencing Services Revenue (2020-2025) & (US$ Million)
Figure 68. Human Microbiome Sequencing Services Industry Chain Mapping
Figure 69. Channels of Distribution (Direct Vs Distribution)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
